Project Grant R21DK150976
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded Johns Hopkins University a Project Grant of $819,091 on September 11, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research titled "Glucose Patterns and Clinical Outcomes in the Dallas Heart Study: A Pathway to Precision Diabetes." The grant extends through June 30, 2030, and funds a comprehensive investigation using...
- Federal Project Grant Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Johns Hopkins University a $169,927 Project Grant (CFDA 93.847: Diabetes, Digestive, and Kidney Diseases Extramural Research) effective April 1, 2026 through March 31, 2031. This award supports research to generate real-world evidence on the comparative effectiveness of glucose-lowering therapies in people with HIV (PWH) and type 2 diabetes. The project addresses a critical...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Johns Hopkins University a $232,875 Project Grant on September 5, 2025, to conduct a mixed-methods study evaluating clinician communication practices around glycemic management for patients with diabetes. Under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), the research will characterize communication quality in primary care visits,...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a K01 Mentored Research Scientist Development Award of $156,982.00 to The Johns Hopkins University, with an award date of September 15, 2025, and completion date of August 31, 2030. Under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), this grant supports Dr. Mary Rooney, PhD, MPH, an Assistant Research Professor at the Johns Hopkins Bloomberg...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Johns Hopkins University a Project Grant of $725,520 beginning September 15, 2025, and concluding June 30, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research focuses on understanding aberrant N-glycosylation in Crohn's disease as a precision medicine opportunity. The project investigates the role of manganese...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $784,276 Project Grant to the University of Houston System on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports the "Supporting Monitoring and Remote Tracking for Prediabetes (SMART Prediabetes)" initiative, a five-year research project extending through June 30, 2031. The project delivers a...
- Federal Project Grant Award Summary The Johns Hopkins University received a $2.33 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 1, 2025, with completion scheduled for August 31, 2029. The award supports research investigating the pathogenesis of necrotizing enterocolitis (NEC), the leading cause of gastrointestinal disease...
- Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Broad Institute, Inc. $882,180 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) beginning September 19, 2025, with completion scheduled for May 31, 2030. This Project Grant supports massive-scale genomic risk assessment to inform precision medicine across the spectrum of monogenic and common forms of diabetes. The primary deliverables...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $786,216 Project Grant to the University of California, Los Angeles (UCLA) on August 28, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a four-year research initiative (through June 30, 2029) investigating post-transcriptional regulation of hepatokines and systemic metabolism. The research focuses on identifying...
- Federal Project Grant Award Summary The University of Chicago received a $172,904 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026, through March 31, 2031. This K23 career development award funds research to develop and validate clinically actionable tools for individualizing glucagon-like peptide-1 receptor agonist (GLP-1RA)...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Johns Hopkins University a Project Grant of $116,625 effective July 1, 2026 through June 30, 2028 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports a two-year secondary data analysis research initiative to identify and validate novel cardiometabolic subtypes in individuals with prediabetes using machine-learning methods. The primary deliverables include the derivation of prediabetes clusters based on cardiometabolic risk factors (including adiposity, liver function, and lipid profiles) and evaluation of associations between these subtypes and clinical outcomes including diabetes incidence, cardiovascular disease, chronic kidney disease, and mortality across multiple U.S. cardiovascular epidemiologic cohorts. This research addresses a critical gap in precision medicine by advancing risk stratification in prediabetes beyond standard glycemic measures. The project will generate evidence-based cardiometabolic subtype classifications intended to enable improved identification of prediabetic individuals who would benefit most from targeted lifestyle and therapeutic interventions, thereby supporting enhanced clinical decision-making and preventive health strategies. Work will be conducted in Baltimore, Maryland at The Johns Hopkins University.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $116.6k | 7/3/26 |